Literature DB >> 6307437

Isoelectric focusing of steroid hormone receptors in slabs of polyacrylamide gel.

O Wrange.   

Abstract

Isoelectric focusing in 1-2 mm thick slabs of polyacrylamide gel is a versatile and specific method for quantitation and characterization of estrogen, mineralocorticoid, progestin, and glucocorticoid receptors. This method has been used for routine measurements of estrogen receptor in human breast cancer in Stockholm since 1976. It is also used for quantitation of estrogen receptor in fine needle biopsies from breast cancer tissue. Isoelectric focusing in gel slabs allows rapid separation (1.5 hr) of receptors from other non-receptor proteins that bind steroid hormones, such as transcortin and sex hormone-binding globulin. The tritium-labeled steroid-receptor complex is localized by slicing the gel followed by radioactivity analysis in a liquid scintillation counter. The isoelectric point of the tritium peak is determined with a surface electrode. The isoelectric point serves as a qualitative control. Thus, only one analysis is needed for each receptor quantitation, provided that a saturating concentration of tritiated ligand is used for receptor binding. This means that a minimal amount of tissue is needed for one receptor analysis with isoelectric focusing.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6307437     DOI: 10.1007/bf01806240

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  16 in total

1.  Formation and characteristics of hepatic dexamethasone-receptor complexes of different molecular weight.

Authors:  J Carlstedt-Duke; J A Gustaffson; O Wrange
Journal:  Biochim Biophys Acta       Date:  1977-04-27

2.  Cytosol estradiol receptor in human mammary carcinoma: an assay based on isoelectric focusing in polyacrylamide gel.

Authors:  O Wrange; B Nordenskjöld; J A Gustafsson
Journal:  Anal Biochem       Date:  1978-04       Impact factor: 3.365

3.  Estrogen receptor assay in human mammary carcinoma with the synthetic estrogen 11beta-methoxy-17alpha-ethinyl-1,3,5(10)-estratriene-3,17beta-diol (R 2858).

Authors:  S Okret; O Wrange; B Nordenskjöld; C Silfverswärd; J A Gustafsson
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

4.  Progestin-receptor analysis in human breast cancer cytosol by isoelectric focusing in slabs of polyacrylamide gel.

Authors:  O Wrange; S Humla; I Ramberg; S A Gustafsson; L Skoog; B Nordenskjöld; J A Gustafsson
Journal:  J Steroid Biochem       Date:  1981-02       Impact factor: 4.292

5.  Macromolecular binding of dexamethasone as evidence for the presence of mineralocorticoid receptor in human breast cancer.

Authors:  P M Martin; P H Rolland; J P Raynaud
Journal:  Cancer Res       Date:  1981-03       Impact factor: 12.701

6.  The estrogen receptor in rat liver: quantitative and qualitative analysis by isoelectric focusing in polyacrylamide gel.

Authors:  O Wrange; G Norstedt; J A Gustafsson
Journal:  Endocrinology       Date:  1980-05       Impact factor: 4.736

7.  Characterization and assay of progesterone receptor in human mammary carcinoma.

Authors:  M F Pichon; E Milgrom
Journal:  Cancer Res       Date:  1977-02       Impact factor: 12.701

8.  Isoelectric focusing of oestradiol receptor protein from human mammary carcinoma--a comparison with dextran coated charcoal assay.

Authors:  E J Lloyd; D M Barnes; L G Skinner
Journal:  J Steroid Biochem       Date:  1982-02       Impact factor: 4.292

9.  A qualitative comparison of the glucocorticoid receptor in cytosol from human brain and rat brain.

Authors:  Z Y Yu; O Wrange; J Boethius; J A Gustafsson; L Granholm
Journal:  Brain Res       Date:  1981-11-02       Impact factor: 3.252

10.  Glucocorticoid receptor concentrations and terminal transferase activity as indicators of prognosis in acute non-lymphocytic leukaemia.

Authors:  L Skoog; B Nordenskjöld; A Ost; B Andersson; R Hast; N Giannoulis; S Humla; T Hägerström; P Reizenstein
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-06
View more
  1 in total

1.  High Levels of Chromosomal Copy Number Alterations and TP53 Mutations Correlate with Poor Outcome in Younger Breast Cancer Patients.

Authors:  Ayla Koçak; Kerstin Heselmeyer-Haddad; Annette Lischka; Daniela Hirsch; David Fiedler; Yue Hu; Natalie Doberstein; Irianna Torres; Wei-Dong Chen; E Michael Gertz; Alejandro A Schäffer; Sandra Freitag-Wolf; Jutta Kirfel; Gert Auer; Jens K Habermann; Thomas Ried
Journal:  Am J Pathol       Date:  2020-05-13       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.